Found: 36
Select item for more details and to access through your institution.
Patients' preferences for once‐daily oral versus once‐weekly injectable diabetes medications: The REVISE study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 508, doi. 10.1111/dom.14244
- By:
- Publication type:
- Article
Real‐world use of cardioprotective glucose‐lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 520, doi. 10.1111/dom.14245
- By:
- Publication type:
- Article
Asymptomatic left ventricular dysfunction in patients with type 2 diabetes free of cardiovascular disease and its relationship with clinical characteristics: The DIACAR cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 434, doi. 10.1111/dom.14236
- By:
- Publication type:
- Article
Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 609, doi. 10.1111/dom.14259
- By:
- Publication type:
- Article
Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 599, doi. 10.1111/dom.14258
- By:
- Publication type:
- Article
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5).
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 619, doi. 10.1111/dom.14257
- By:
- Publication type:
- Article
COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 589, doi. 10.1111/dom.14256
- By:
- Publication type:
- Article
Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 581, doi. 10.1111/dom.14255
- By:
- Publication type:
- Article
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 569, doi. 10.1111/dom.14254
- By:
- Publication type:
- Article
Use of dipeptidyl peptidase‐4 inhibitors and risk of splanchnic vein thrombosis: A Danish nationwide new‐user active comparator cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 648, doi. 10.1111/dom.14253
- By:
- Publication type:
- Article
Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 561, doi. 10.1111/dom.14252
- By:
- Publication type:
- Article
Use of sodium‐glucose co‐transporter‐2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 299, doi. 10.1111/dom.14251
- By:
- Publication type:
- Article
Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT‐1 and ‐2 studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 549, doi. 10.1111/dom.14248
- By:
- Publication type:
- Article
Benefits of continuous positive airway pressure on glycaemic control and insulin resistance in patients with type 2 diabetes and obstructive sleep apnoea: A meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 540, doi. 10.1111/dom.14247
- By:
- Publication type:
- Article
No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE‐D trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 530, doi. 10.1111/dom.14246
- By:
- Publication type:
- Article
Antidiabetic medication use in commercially insured children and adolescents in the United States from 2004 to 2019.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 444, doi. 10.1111/dom.14237
- By:
- Publication type:
- Article
Risk of developing diabetes in patients with atrial fibrillation taking non‐vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 499, doi. 10.1111/dom.14243
- By:
- Publication type:
- Article
Effect of the glucagon‐like peptide‐1 analogue liraglutide versus placebo treatment on circulating proglucagon‐derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 489, doi. 10.1111/dom.14242
- By:
- Publication type:
- Article
Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 480, doi. 10.1111/dom.14241
- By:
- Publication type:
- Article
Renal outcomes and all‐cause death associated with sodium‐glucose co‐transporter‐2 inhibitors versus other glucose‐lowering drugs (CVD‐REAL 3 Korea).
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 455, doi. 10.1111/dom.14239
- By:
- Publication type:
- Article
Building clinical risk score systems for predicting the all‐cause and expanded cardiovascular‐specific mortality of patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 467, doi. 10.1111/dom.14240
- By:
- Publication type:
- Article
Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 631, doi. 10.1111/dom.14238
- By:
- Publication type:
- Article
Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add‐on to metformin in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 425, doi. 10.1111/dom.14234
- By:
- Publication type:
- Article
Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30‐week, double‐blind, phase 3a, randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 404, doi. 10.1111/dom.14232
- By:
- Publication type:
- Article
Cerebral effects of glucagon‐like peptide‐1 receptor blockade before and after Roux‐en‐Y gastric bypass surgery in obese women: A proof‐of‐concept resting‐state functional MRI study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 415, doi. 10.1111/dom.14233
- By:
- Publication type:
- Article
Efficacy and safety of linagliptin as add‐on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 642, doi. 10.1111/dom.14231
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 382, doi. 10.1111/dom.14226
- By:
- Publication type:
- Article
Relationship between obesity and severe COVID‐19 outcomes in patients with type 2 diabetes: Results from the CORONADO study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 391, doi. 10.1111/dom.14228
- By:
- Publication type:
- Article
Efficacy and safety of exenatide as add‐on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double‐blind trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 374, doi. 10.1111/dom.14225
- By:
- Publication type:
- Article
Design and baseline characteristics of the AMPLITUDE‐O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 318, doi. 10.1111/dom.14223
- By:
- Publication type:
- Article
A phase 3 randomized clinical trial using a once‐weekly glucagon‐like peptide‐1 receptor agonist in adolescents and young adults with hypothalamic obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 363, doi. 10.1111/dom.14224
- By:
- Publication type:
- Article
Is routine measurement of the serum C‐reactive protein level helpful during antibiotic therapy for diabetic foot infection?
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 637, doi. 10.1111/dom.14222
- By:
- Publication type:
- Article
Hypoglycaemia in type 2 diabetes exacerbates amyloid‐related proteins associated with dementia.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 338, doi. 10.1111/dom.14220
- By:
- Publication type:
- Article
The impact of pharmacological and lifestyle interventions on body weight in people with type 1 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 350, doi. 10.1111/dom.14221
- By:
- Publication type:
- Article
The PREVIEW intervention study: Results from a 3‐year randomized 2 x 2 factorial multinational trial investigating the role of protein, glycaemic index and physical activity for prevention of type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 324, doi. 10.1111/dom.14219
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 297, doi. 10.1111/dom.13776
- Publication type:
- Article